Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective

被引：45

作者：

Murdoch, DR ^{[1
]}

Reller, LB ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Clin Microbiol Lab, Durham, NC 27710 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 12期

关键词：

D O I：

10.1128/AAC.45.12.3623-3624.2001

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.

引用

页码：3623 / 3624

页数：2

共 11 条

[1] HIGH-LEVEL CHROMOSOMAL GENTAMICIN RESISTANCE IN STREPTOCOCCUS-AGALACTIAE (GROUP-B) [J].

BUUHOI, A ;

LEBOUGUENEC, C ;

HORAUD, T .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :985-988

[2]

Edwards MS, 2000, PRINCIPLES PRACTICE, P2156

[3] Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis [J].

Fernandez, M ;

Hickman, ME ;

Baker, CJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1517-1519

[4] RANDOMIZED COMPARISON OF MEROPENEM WITH CEFOTAXIME FOR TREATMENT OF BACTERIAL-MENINGITIS [J].

KLUGMAN, KP ;

DAGAN, R ;

WILLIAMS, KJ ;

FEATHERSTONE, A ;

BEATTY, D ;

LEARY, M ;

WALKER, K ;

RODDA, J ;

SCHER, G ;

HOUSEHAM, C ;

PELSAR, H ;

LOPEZ, E ;

FALLO, L ;

TREGNAGHI, MW ;

AIRD, A ;

DEAPRA, EQ ;

BEGUE, P ;

BOULESTEIX, J ;

FLORET, D ;

ASTRUC, J ;

BOUILLE, C ;

CARRIERE, JP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1140-1146

[5] Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998 [J].

Lin, FYC ;

Azimi, PH ;

Weisman, LE ;

Philips, JB ;

Regan, J ;

Clark, P ;

Rhoads, GG ;

Clemens, J ;

Troendle, J ;

Pratt, E ;

Brenner, RA ;

Gill, V .

CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) :76-79

[6] Change in antibiotic resistance of group B Streptococcus:: Impact on intrapartum management [J].

Morales, WJ ;

Dickey, SS ;

Bornick, P ;

Lim, DV .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (02) :310-312

[7]

National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE

[8] Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin [J].

Pearlman, MD ;

Pierson, CL ;

Faix, RG .

OBSTETRICS AND GYNECOLOGY, 1998, 92 (02) :258-261

[9] Antibiotic susceptibility profile of group B streptococcus acquired vertically [J].

Rouse, DJ ;

Andrews, WW ;

Lin, FYC ;

Mott, CW ;

Ware, JC ;

Philips, JB .

OBSTETRICS AND GYNECOLOGY, 1998, 92 (06) :931-934

[10] Invasive disease due to group B streptococcal infection in adults: Results from a Canadian, population-based, active laboratory surveillance study - 1996 [J].

Tyrrell, GJ ;

Senzilet, LD ;

Spika, JS ;

Kertesz, DA ;

Alagaratnam, M ;

Lovgren, M ;

Talbot, JA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :168-173

← 1 2 →